Due to reorganisation of stock levels, a pharmaceutical manufacturer is offering stainless steel vessels and stock of unused engineering spares to the process industry for auction.
Due to reorganisation of stock levels, a pharmaceutical manufacturer is offering stainless steel vessels and stock of unused engineering spares to the process industry for auction. Viewing is strictly by appointment with the auctioneers.
South Dublin City, Ireland
Bidding closes: 2pm Thursday 25 February 2010
For auction:
Stainless steel vessels and stock of unused engineering spares for the process industry
20 Stainless steel vessels (1003000 Litre cap.); electric motors (to 55kW) from ABB, Brook Crompton, Brook Hansen and Siemens; pumps (including centrifugal and diaphragm) by Fristam Pumps, Grundfos and Siemens etc.; heat exchangers; valves, seals; actuators; sensors; modules; transmitters; speed controllers; flowmeters; analyzers; electronic equipment etc.
Cost value: approximately 1.2 million Euros
Photographs and online auction bidding viawww.bidspotter.co.uk
Also available for sale by Private Treaty (on behalf of a retained client):
Farmomac Model F67 rotary filling line; 80-90 units/min cap.; 15 mL bottles; fitted with Hoppman bottle sorter and feeder; 4 filling heads and 4 pumps; 12 head tip fitting unit; screw cap bowl and capping station; and vision inspection system. Year of manufacture is 1993.
The system is available for viewing by appointment at Westport, Co. Mayo (Ireland).
http://www.sandersonweatherall.com/html/left-links/machinery/details/?ContentID=95
In association with Lisney, Chartered Surveyors
24 St Stephens Green, Dublin 2, Ireland
Tel: +353 (0) 1 638 2700
Fax: +353 (0) 1 676 6025
www.lisney.comjprunty@lisney.com
Sanderson Weatherall
Brook House, 64-72 Spring Gardens, Manchester, M2 2BQ, UK
Tel: +44 (0) 161 259 7000
Fax: +44 (0) 161 259 7007
auctions@sandersonweatherall.comwww.sandersonweatherall.com
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.